Letters to the Editor
New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc
M. Guarda1, P.A. Araoz2, U. Ghaffar3, K.J. Warrington4, M.J. Koster5
- Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
- Department of Radiology, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division ofnRheumatology, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA. koster.matthew@mayo.edu
CER16534
2023 Vol.41, N°4
PI 0989, PF 0990
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 36995327 [PubMed]
Received: 24/01/2023
Accepted : 03/02/2023
In Press: 20/03/2023
Published: 18/04/2023
